Effect of parameter <i>a</i> on the model equations by increasing and decreasing value of <i>a</i> to 25%. by Shakoor Ahmad (168711)

“…<p><b>(a)</b> By increasing the value ‘<i>a</i>’ from 0.107 to 0.134. <b>(b)</b> By decreasing the value ‘<i>a</i>’ from 0.107 to 0.08.…”

TITAN decreaser macroinvertebrate heatmap Heatmap of sensitive (i.e., <i>z-</i>) macroinvertebrate taxa (y-axis) to at least one of the five stressors, in decreasing order of numbe... by Brent J. Bellinger (21156150)

Method for the Large-Scale Synthesis of Multifunctional 1,4-Dihydro-pyrrolo[3,2‑<i>b</i>]pyrroles by Mariusz Tasior (1457731)

“…A thorough investigation has enabled the optimization of the synthesis of 1,4-dihydro-pyrrolo­[3,2-<i>b</i>]­pyrroles. Although salts of such metals as vanadium, niobium, cerium, and manganese were found to facilitate the formation of 1,4-dihydro-pyrrolo­[3,2-<i>b</i>]­pyrroles from amines, aldehydes, and diacetyl, we confirmed that iron salts are the most efficient catalysts. …”

Method for the Large-Scale Synthesis of Multifunctional 1,4-Dihydro-pyrrolo[3,2‑<i>b</i>]pyrroles by Mariusz Tasior (1457731)

“…A thorough investigation has enabled the optimization of the synthesis of 1,4-dihydro-pyrrolo­[3,2-<i>b</i>]­pyrroles. Although salts of such metals as vanadium, niobium, cerium, and manganese were found to facilitate the formation of 1,4-dihydro-pyrrolo­[3,2-<i>b</i>]­pyrroles from amines, aldehydes, and diacetyl, we confirmed that iron salts are the most efficient catalysts. …”

Benchmarking DFT Accuracy in Predicting O 1s Binding Energies on Metals by Elizabeth E. Happel (22391811)

Subjects:

Benchmarking DFT Accuracy in Predicting O 1s Binding Energies on Metals by Elizabeth E. Happel (22391811)

Subjects:

Cellular immune components of the pre-castration and post-castration within the tumor. by Nourridine Siewe (5081834)

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Frailty and mortality of women and men. by Carl-Johan Dalgaard (12836996)

Preparatory neuronal activity in ALM is decreased, but remains significant in quiet trials devoid of movements. by Vahid Esmaeili (12700352)

The number of expected vaccinations decreases with the expected vaccination time, whereas the peak of infections increases. by Simon K. Schnyder (16632244)

Costs and Benefits of Popular <i>P</i>‑Value Correction Methods in Three Models of Quantitative Omic Experiments by Steven R. Shuken (14500192)

“…We show how increasing sample size, decreasing variability, or increasing effect size can enable the detection of all true changes while still correcting <i>p</i>-values, and we present basic guidelines for omic experimental design. …”

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Amino acids eigenvector centrality values mapped on the protein structure of the following Spike variants: a) Omicron₁; b) Wild Type; c) Delta. by Ugo Lomoio (16624608)

“…The decrease of eigenvector centrality of RBD domain of the Omicron₁ variants is shown by the presence of a larger number of blue colored nodes.…”

Species occurrence along the NO₃¯ gradient (sorted by decreasing 25th percentile values). by Willem Kaijser (12872371)

Influence of the posterior cross vein (PCV) position on <i>A</i>_S / <i>A</i>_C. by Kazuki Sugiyama (1433809)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)